Core Insights - The ChiNext Mid-Cap 200 Index declined by 2.8%, the ChiNext Index fell by 3.2%, and the ChiNext Growth Index decreased by 3.6% during the midday close, indicating a bearish trend in the market [1] - Despite the overall decline, there was a significant inflow of funds into the ChiNext ETF (159915), with a net subscription exceeding 700 million yuan in just half a day [1] - The ChiNext ETF has seen a continuous net inflow of funds for five consecutive trading days, totaling approximately 2.5 billion yuan [1]

Group 1 - The Hang Seng Hong Kong Stock Connect Innovative Drug Index decreased by 3.0% [1] - The CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index fell by 2.8% [1] - The CSI Innovative Drug Industry Index declined by 2.3% [1] Group 2 - The CSI Biotechnology Theme Index and the CSI 300 Pharmaceutical and Health Index both dropped by 1.8% [1] - Despite the market downturn, there was a significant net subscription for the Hang Seng Innovative Drug ETF (159316) and the Biotechnology ETF (159837), with net subscriptions reaching 44 million units and 40 million units respectively [1]